Actuate Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Actuate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Actuate Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actuate Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $31k | 11k | 2.74 |
| 2025-12-31 | $146k | 24k | 6.12 |
| 2025-09-30 | $99k | 15k | 6.69 |
| 2025-06-30 | $90k | 15k | 6.11 |